XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Condensed Statements of Operations (Unaudited) - USD ($)
shares in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue (Note 2) $ 11,439,100,000 $ 9,498,600,000 $ 31,509,900,000 $ 24,770,700,000
Costs, expenses, and other:        
Cost of sales 2,170,800,000 1,860,100,000 6,014,500,000 5,294,200,000
Research and development 2,734,100,000 2,409,100,000 7,968,100,000 6,750,700,000
Marketing, selling, and administrative 2,099,800,000 1,803,900,000 6,169,300,000 5,478,500,000
Acquired in-process research and development (Note 3) 2,826,400,000 2,975,100,000 3,091,200,000 3,177,200,000
Asset impairment, restructuring, and other special charges (Note 5) 81,600,000 0 516,600,000 0
Other–net, (income) expense (Note 12) (62,000,000.0) 23,200,000 108,500,000 24,300,000
Costs, expenses, and other 9,850,700,000 9,071,400,000 23,868,200,000 20,724,900,000
Income before income taxes 1,588,400,000 427,200,000 7,641,700,000 4,045,800,000
Income taxes (Note 8) 618,100,000 484,600,000 1,461,500,000 995,100,000
Net income (loss) $ 970,300,000 $ (57,400,000) $ 6,180,200,000 $ 3,050,700,000
Earnings (loss) per share:        
Basic (in dollars per share) $ 1.08 $ (0.06) $ 6.86 $ 3.39
Diluted (in dollars per share) $ 1.07 $ (0.06) $ 6.83 $ 3.38
Shares used in calculation of earnings (loss) per share:        
Basic (in shares) 901.0 899.8 900.9 900.2
Diluted (in shares) 905.0 899.8 904.4 903.1